Chemomab Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.7%.

Top 21 shareholders own 36.81% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.8%	OrbiMed Advisors LLC	2,241,274	€1.9m	0%	0.03%
7.8%	Peter Thiel	1,108,509	€947.6k	0%	no data
5.11%	Presight Capital	727,163	€621.6k	0%	3.99%
4%	Adi George	568,222	€485.7k	0%	no data
1.5%	Ikarian Capital, LLC	213,392	€182.4k	0%	0.07%
1.06%	Neil Cohen	151,218	€129.3k	0%	no data
0.28%	Two Sigma Investments, LP	39,994	€34.2k	-29%	no data
0.27%	Two Sigma Advisers, LP	37,800	€32.3k	6.78%	no data
0.22%	Kestra Private Wealth Services, LLC	31,241	€26.7k	0%	no data
0.19%	Boothbay Fund Management, LLC	26,529	€22.7k	0%	no data
0.18%	Two Sigma Securities, LLC, Asset Management Arm	26,185	€22.4k	0%	no data
0.14%	Rhumbline Advisers Ltd Partnership	19,877	€17.0k	6.71%	no data
0.11%	Sigal Fattal	15,002	€12.8k	0%	no data
0.083%	Geode Capital Management, LLC	11,737	€10.0k	0%	no data
0.081%	Susquehanna International Group, LLP, Asset Management Arm	11,477	€9.8k	0%	no data
0.02%	Morgan Stanley, Investment Banking and Brokerage Investments	2,797	€2.4k	-96.1%	no data
0.0084%	Nissim Darvish	1,200	€1.0k	0%	no data
0.0035%	Moser Wealth Advisors, LLC	500	€427.8	0%	no data
0.0014%	Blackstone Alternative Investment Advisors LLC	200	€171.4	100%	no data
0.00031%	Qube Research & Technologies Ltd	44	€37.7	0%	no data
0.00001%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€1.2	0%	no data